Autologous stem cell transplantation versus consolidation chemotherapy as postremission treatment in newly diagnosed favorable- and intermediate-risk patients with AML: A comparative analysis of HOVON-SAKK-Nordic trials

Kotsos, Dimitrios, Hazenberg, Carin, Pabst, Thomas, Gradowska, Patrycja, Manz, Markus G, Maertens, Johan, Graux, Carlos, Vekemans, Marie-Christiane, Gjertsen, Bjorn T, Lehmann, Sören, Van Elssen, Catharina H M J, Valk, Peter J M, Vellenga, Edo, Ossenkoppele, Gert, Löwenberg, Bob, Raaijmakers, Marc H G P, Huls, Gerwin, Versluis, Jurjen

Open source

DOI: 10.5167/uzh-437229
Published: 2026
Container: Not recorded
Publisher: Wiley-Blackwell Publishing, Inc.
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.5167/uzh-437229,
  title = {Autologous stem cell transplantation versus consolidation chemotherapy as postremission treatment in newly diagnosed favorable- and intermediate-risk patients with AML: A comparative analysis of HOVON-SAKK-Nordic trials},
  author = {Kotsos, Dimitrios and Hazenberg, Carin and Pabst, Thomas and Gradowska, Patrycja and Manz, Markus G and Maertens, Johan and Graux, Carlos and Vekemans, Marie-Christiane and Gjertsen, Bjorn T and Lehmann, Sören and Van Elssen, Catharina H M J and Valk, Peter J M and Vellenga, Edo and Ossenkoppele, Gert and Löwenberg, Bob and Raaijmakers, Marc H G P and Huls, Gerwin and Versluis, Jurjen},
  year = {2026},
  doi = {10.5167/uzh-437229},
  url = {https://doi.org/10.5167/uzh-437229}
}

RIS

TY  - JOUR
TI  - Autologous stem cell transplantation versus consolidation chemotherapy as postremission treatment in newly diagnosed favorable- and intermediate-risk patients with AML: A comparative analysis of HOVON-SAKK-Nordic trials
AU  - Kotsos, Dimitrios
AU  - Hazenberg, Carin
AU  - Pabst, Thomas
AU  - Gradowska, Patrycja
AU  - Manz, Markus G
AU  - Maertens, Johan
AU  - Graux, Carlos
AU  - Vekemans, Marie-Christiane
AU  - Gjertsen, Bjorn T
AU  - Lehmann, Sören
AU  - Van Elssen, Catharina H M J
AU  - Valk, Peter J M
AU  - Vellenga, Edo
AU  - Ossenkoppele, Gert
AU  - Löwenberg, Bob
AU  - Raaijmakers, Marc H G P
AU  - Huls, Gerwin
AU  - Versluis, Jurjen
PY  - 2026
DO  - 10.5167/uzh-437229
UR  - https://doi.org/10.5167/uzh-437229
ER  -

APA

Dimitrios, K., Carin, H., Thomas, P., Patrycja, G., G, M. M., Johan, M., Carlos, G., Marie-Christiane, V., T, G. B., Sören, L., J, V. E. C. H. M., M, V. P. J., Edo, V., Gert, O., Bob, L., P, R. M. H. G., Gerwin, H., & Jurjen, V. (2026). Autologous stem cell transplantation versus consolidation chemotherapy as postremission treatment in newly diagnosed favorable- and intermediate-risk patients with AML: A comparative analysis of HOVON-SAKK-Nordic trials. https://doi.org/10.5167/uzh-437229

Source records

datacite · retrieved 2026-11-10T09:31:10.015Z